Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy.
There is increasing evidence to suggest that hepatic encephalopathy in acute liver failure is the result of altered glutamatergic function. In particular, the high affinity uptake of glutamate is decreased in brain slices and synaptosomes from rats with acute liver failure as well as by exposure of cultured astrocytes to concentrations of ammonia equivalent to those reported in brain in acute liver failure. Both protein and gene expression of the recently cloned and sequenced astrocytic glutamate transporter GLT-1 are significantly reduced in the brains of rats with acute liver failure. Decreased expression of GLT-1 in brain in acute liver failure results in increased extracellular brain glutamate concentrations which correlates with arterial ammonia concentrations and with the appearance of severe encephalopathy and brain edema in these animals. Ammonia-induced reductions in expression of GLT-1 resulting in increased extracellular glutamate concentrations could explain some of the symptoms (hyperexcitability, cerebral edema) characteristic of hepatic encephalopathy in acute liver failure.
Chan
H
H
Neuroscience Research Unit, CHUM, Montreal, Quebec, Canada.
Butterworth
R F
RF
D018528:ATP-Binding Cassette Transporters / Q000235:genetics* / Q000378:metabolism*; D027322:Amino Acid Transport System X-AG; D000641:Ammonia / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D015870:Gene Expression; D018698:Glutamic Acid / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000209:etiology*; D006801:Humans
D018528:ATP-Binding Cassette Transporters; D027322:Amino Acid Transport System X-AG; D018698:Glutamic Acid; D000641:Ammonia